Toronto Dominion Bank’s Zimmer Biomet ZBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$5.25M Sell
58,097
-8,072
-12% -$741K 0.01% 837
2025
Q4
$5.95M Sell
66,169
-6,689
-9% -$634K 0.01% 798
2025
Q3
$7.18M Sell
72,858
-7,397
-9% -$733K 0.01% 713
2025
Q2
$7.32M Sell
80,255
-5,704
-7% -$552K 0.01% 666
2025
Q1
$9.73M Buy
85,959
+18,159
+27% +$1.94M 0.02% 509
2024
Q4
$7.16M Sell
67,800
-947
-1% -$102K 0.01% 616
2024
Q3
$7.42M Buy
68,747
+8,710
+15% +$951K 0.01% 535
2024
Q2
$6.52M Sell
60,037
-60,967
-50% -$7.19M 0.01% 588
2024
Q1
$16M Buy
121,004
+2,456
+2% +$307K 0.03% 376
2023
Q4
$14.4M Buy
118,548
+9,845
+9% +$1.1M 0.02% 459
2023
Q3
$12.2M Sell
108,703
-6,013
-5% -$764K 0.02% 455
2023
Q2
$16.7M Buy
114,716
+4,968
+5% +$675K 0.02% 408
2023
Q1
$14.2M Buy
109,748
+111
+0.1% +$13.9K 0.02% 413
2022
Q4
$14M Buy
109,637
+17,485
+19% +$2.03M 0.02% 421
2022
Q3
$9.63M Sell
92,152
-15,427
-14% -$1.69M 0.02% 485
2022
Q2
$11.3M Sell
107,579
-17,928
-14% -$2.13M 0.02% 381
2022
Q1
$16.1M Sell
125,507
-21,232
-14% -$2.56M 0.02% 342
2021
Q4
$18.1M Buy
146,739
+29,713
+25% +$3.89M 0.02% 367
2021
Q3
$16.6M Buy
117,026
+22,963
+24% +$3.38M 0.03% 339
2021
Q2
$14.7M Sell
94,063
-82,170
-47% -$13.3M 0.02% 375
2021
Q1
$27.4M Buy
176,233
+42,971
+32% +$6.66M 0.05% 219
2020
Q4
$19.9M Buy
133,262
+13,063
+11% +$1.84M 0.04% 283
2020
Q3
$15.9M Sell
120,199
-19,594
-14% -$2.56M 0.04% 274
2020
Q2
$16.2M Sell
139,793
-20,172
-13% -$2.32M 0.04% 302
2020
Q1
$15.7M Sell
159,965
-37,349
-19% -$4.9M 0.05% 259
2019
Q4
$28.7M Buy
197,314
+41,681
+27% +$5.75M 0.05% 240
2019
Q3
$20.7M Sell
155,633
-164,163
-51% -$21.2M 0.04% 279
2019
Q2
$18.3M Buy
319,796
+173,555
+119% +$20.3M 0.04% 305
2019
Q1
$18.1M Buy
146,241
+20,854
+17% +$2.37M 0.03% 324
2018
Q4
$12.6M Sell
125,387
-10,811
-8% -$1.22M 0.02% 349
2018
Q3
$17.4M Buy
136,198
+1,618
+1% +$192K 0.03% 311
2018
Q2
$14.6M Buy
134,580
+21,835
+19% +$2.38M 0.03% 354
2018
Q1
$11.9M Buy
112,745
+22,929
+26% +$2.66M 0.03% 359
2017
Q4
$10.5M Buy
89,816
+10,842
+14% +$1.23M 0.03% 329
2017
Q3
$8.98M Buy
78,974
+8,775
+13% +$1.01M 0.03% 326
2017
Q2
$8.75M Buy
70,199
+14,308
+26% +$1.7M 0.03% 307
2017
Q1
$6.63M Buy
55,891
+19,285
+53% +$2.19M 0.02% 343
2016
Q4
$3.67M Buy
36,606
+30,592
+509% +$3.28M 0.01% 379
2016
Q3
$759K Buy
6,014
+4,890
+435% +$604K ﹤0.01% 494
2016
Q2
$131K Sell
1,124
-371
-25% -$42K ﹤0.01% 650
2016
Q1
$155K Sell
1,495
-3,971
-73% -$384K ﹤0.01% 616
2015
Q4
$544K Sell
5,466
-198
-3% -$19.4K ﹤0.01% 499
2015
Q3
$517K Buy
5,664
+760
+15% +$76.2K ﹤0.01% 493
2015
Q2
$520K Buy
4,904
+29
+0.6% +$3.21K ﹤0.01% 533
2015
Q1
$556K Sell
4,875
-2,384
-33% -$272K ﹤0.01% 502
2014
Q4
$800K Buy
7,259
+3,913
+117% +$412K ﹤0.01% 461
2014
Q3
$321K Buy
3,346
+22
+0.7% +$2.16K ﹤0.01% 515
2014
Q2
$335K Buy
3,324
+478
+17% +$46.6K ﹤0.01% 596
2014
Q1
$262K Sell
2,846
-27
-0.9% -$2.49K ﹤0.01% 632
2013
Q4
$260K Buy
2,873
+2,811
+4,534% +$243K ﹤0.01% 599
2013
Q3
$5K Hold
62
﹤0.01% 728
2013
Q2
$5K Buy
+62
New +$4.64K ﹤0.01% 748

Other funds holding ZBH

Toronto Dominion Bank's ZBH Position: Q1 2026 in Review

Toronto Dominion Bank reduced its Zimmer Biomet (ZBH) stake by 12% in Q1 2026, selling an estimated $741K and leaving 58,097 shares worth $5.25M. The position accounts for 0.01% of the portfolio, ranked #837.

Toronto Dominion Bank first reported a position in ZBH in Q2 2013 and has held it in 52 quarters since. The position peaked at $28.7M in Q4 2019. 912 funds tracked by Wall St. Rank hold ZBH as of Q1 2026.

  • Toronto Dominion Bank held 58,097 shares of Zimmer Biomet worth $5.25M as of Q1 2026.
  • Toronto Dominion Bank sold 8,072 Zimmer Biomet shares in Q1 2026, an estimated $741K.
  • Zimmer Biomet made up 0.01% of Toronto Dominion Bank's portfolio in Q1 2026, its #837 holding.
  • Toronto Dominion Bank first reported a position in Zimmer Biomet in Q2 2013 and has held it in 52 quarters since.
  • Toronto Dominion Bank's Zimmer Biomet position peaked at $28.7M in Q4 2019.
  • 912 funds tracked by Wall St. Rank held Zimmer Biomet as of Q1 2026.

Based on Toronto Dominion Bank's 13F filing for Q1 2026, filed 15 May 2026.